Today: 27 May 2026
Genting Singapore share price dips as Feb 24 earnings date nears and RWS revamp stays in focus
21 January 2026
1 min read

Genting Singapore share price dips as Feb 24 earnings date nears and RWS revamp stays in focus

Singapore, Jan 21, 2026, 15:25 SGT — Regular session

  • Shares of Genting Singapore slipped 1.37% to S$0.720, hovering close to the session’s low in afternoon trading.
  • The company scheduled its full-year results release for Feb. 24, after trading hours.
  • CEO Lee Shi Ruh described 2026 as a “testing period” for Resorts World Sentosa ahead of its licence review.

Genting Singapore shares dropped 1.37% to S$0.720 by 3:14 p.m. Wednesday in Singapore, hitting the session’s lowest point. The stock opened at S$0.725 and briefly climbed to S$0.730 before sliding. About 28.6 million shares changed hands.

Resorts World Sentosa’s operator announced it plans to publish its full-year financial results for the period ending Dec. 31, 2025, on Tuesday, Feb. 24, after the market closes, according to a filing with the Singapore Exchange. The company will also make the results available on its website.

The next major milestone for investors sizing up the company’s efforts to revamp its resort is set for 2026. Resorts World Sentosa CEO Lee Shi Ruh described 2026 as a “testing period,” aiming to introduce “something new every two to three weeks,” according to InterGame. InterGame

Genting Singapore operates one of Singapore’s two casinos, located at Resorts World Sentosa. This integrated resort combines a casino with hotels, attractions, and convention facilities.

Investors will zero in on the Feb. 24 report for new insights into how the latest attractions and retail initiatives are resonating with guests—and what impact that’s having on spending per visitor. Updates on the speed and expenses tied to the RWS 2.0 redevelopment plan will also be closely monitored.

Wednesday’s action was modest in points but unmistakably downward: a one-cent decline pushed the stock to the low end of its intraday range, with heavy volume for a Singapore-listed stock.

But the licence review still holds the key. If regulators take a harder line than anticipated, or if the resort fails to boost incremental tourism spending, it could swiftly shift expectations for the results.

The next key date is set: Feb. 24, post-close, when Genting Singapore reports its full-year results. The session that follows will reveal just how much of the revamp and licence story is baked into the stock.

Stock Market Today

  • SPY Falls 0.2% Driven by 10.8% Drop in BSX Stock
    May 27, 2026, 1:25 PM EDT. The SPDR S&P 500 ETF Trust ($SPY) declined 0.2% today, weighed notably by Boston Scientific ($BSX), which fell 10.8%. Other significant SPY holdings that declined include Nvidia ($NVDA) down 2.3%, JPMorgan Chase ($JPM) down 3.0%, and Qualcomm ($QCOM) down 9.0%. Insider activity at BSX shows mixed trades with CEO Michael Mahoney selling shares totaling $15 million, while others increased holdings. Wall Street analysts maintain a positive outlook on BSX, with multiple recent "Buy" ratings and a median price target of $87.0 set by 21 analysts over six months. Data sourced from Polygon and Quiver Quantitative underscores ongoing market sensitivities and insider transactions impacting SPY's performance.

Latest articles

Astrotech Stock Rockets 500% After Moon Quantum Plan — The Risk Traders Should Watch

Astrotech Stock Rockets 500% After Moon Quantum Plan — The Risk Traders Should Watch

27 May 2026
Astrotech Corp shares surged 524% to $15.42 Wednesday after the company announced plans to explore lunar resource development and Moon-based semiconductor manufacturing. Trading volume topped 111 million shares, pushing market value to about $26 million. The company has no NASA contracts and reported a $3.8 million quarterly loss on $343,000 revenue. Astrotech’s core business remains mass spectrometry and gas chromatography.
Verra Mobility shares slide 70% after Avis drops out

Verra Mobility shares slide 70% after Avis drops out

27 May 2026
Verra Mobility shares plunged 71.4% to $3.74 after Avis Budget said it will end its contract in September 2026. Avis accounted for over 10% of Verra’s revenue in early 2025. Verra cut its 2026 forecast, projecting a $135–$145 million annual revenue hit. Deutsche Bank, Baird, and JPMorgan downgraded the stock following the announcement.
Boston Scientific Hits Two-Year Low After Watchman Device Warning

Boston Scientific Hits Two-Year Low After Watchman Device Warning

27 May 2026
Boston Scientific shares fell about 10% Wednesday after CEO Mike Mahoney warned of weaker demand for its Watchman heart implant. The stock hit $50.60, its lowest in over two years. Mahoney said Watchman sales likely won’t grow from the first to third quarter, citing a shift to combined procedures. The company maintained its full-year organic revenue growth forecast of 6.5% to 8%.
Singtel stock price dips as tariff jitters rattle Singapore market ahead of Feb 18 earnings
Previous Story

Singtel stock price dips as tariff jitters rattle Singapore market ahead of Feb 18 earnings

BAE Systems share price: fresh buyback filing hits tape before London open
Next Story

BAE Systems share price: fresh buyback filing hits tape before London open

Go toTop